Optamont (Olopatadine)

Olopatadine, the active ingredient in Optamont, is a selective H1‑histamine receptor antagonist presented as an ophthalmic solution for ocular use. It reduces itching, redness, and swelling caused by allergic reactions in the eye and is indicated for the treatment of allergic conjunctivitis in adults and children.

GNH USA supplies Optamont as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers across multiple regions globally.

Olopatadine is an antihistamine that targets ocular and nasal allergic responses.

Allergic conjunctivitis: reduces eye itching, redness, and swelling. Seasonal allergic rhinitis: alleviates nasal itching, sneezing, and rhinorrhea. Perennial allergic rhinitis: improves chronic nasal allergy symptoms. Allergic keratoconjunctivitis: controls inflammation of the cornea and conjunctiva. Vernal keratoconjunctivitis: provides symptomatic relief in severe seasonal eye allergy.

Olopatadine may cause a range of adverse reactions, varying from mild to rare serious events.

Common Side Effects: - Eye irritation or burning sensation. - Headache. - Bitter taste after administration. - Dry eye or transient blurred vision. - Mild pruritus of the peri‑ocular skin. - Transient photophobia.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) with swelling of face or throat. - Corneal ulcer or keratitis. - Persistent intraocular pressure elevation.

When using Optamont, consider the following precautions:

Pregnancy: safety not established; use only if benefit outweighs risk. Breastfeeding: limited data; consider potential risk to infant. Driving: may cause mild visual disturbances; exercise caution when operating machinery. Concomitant antihistamines: increased risk of sedation; monitor patient response. Avoid use in patients with known hypersensitivity to olopatadine or excipients. Store at below 25°C: keep in original container, protect from moisture and light.

Olopatadine can interact with other medicines; review the following categories.

Major Interactions (Avoid): - Concurrent use with other H1 antihistamine eye drops: additive ocular irritation may occur. - Use with monoamine oxidase inhibitors: theoretical risk of hypertensive reactions.

Moderate Interactions (Monitor Closely): - Alcohol consumption: may enhance drowsiness. - CYP3A4 inhibitors (e.g., ketoconazole): may increase olopatadine plasma levels. - Anticholinergic agents: may worsen dry‑eye symptoms.